美国婴儿脑膜炎球菌病负担 - Suppr

The Burden of Infant Meningococcal Disease in the United States.

作者信息

Judelsohn R, Marshall G S

机构信息

School of Medicine, State University of New York at Buffalo.

Division of Pediatric Infectious Diseases, University of Louisville School of Medicine, Kentucky

出版信息

J Pediatric Infect Dis Soc. 2012 Mar;1(1):64-73. doi: 10.1093/jpids/pir003. Epub 2012 Mar 1.

DOI:10.1093/jpids/pir003

PMID:23687573

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3656548/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ea/3656548/95902b4e03bb/pir00301.jpg

相似文献

The Burden of Infant Meningococcal Disease in the United States.

J Pediatric Infect Dis Soc. 2012 Mar;1(1):64-73. doi: 10.1093/jpids/pir003. Epub 2012 Mar 1.

Epidemiology of infant meningococcal disease in the United States, 2006-2012.

Pediatrics. 2015 Feb;135(2):e305-11. doi: 10.1542/peds.2014-2035. Epub 2015 Jan 12.

Neonatal meningococcal disease in the United States, 1990 to 1999.

Pediatr Infect Dis J. 2003 May;22(5):418-22. doi: 10.1097/01.inf.0000066876.77453.04.

Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease.

Clin Infect Dis. 2010 Jan 15;50(2):184-91. doi: 10.1086/649209.

History of Meningococcal Outbreaks in the United States: Implications for Vaccination and Disease Prevention.

Pharmacotherapy. 2016 Aug;36(8):880-92. doi: 10.1002/phar.1790.

Opportunities for control of meningococcal disease in the United States.

Annu Rev Med. 2004;55:333-53. doi: 10.1146/annurev.med.55.091902.103612.

Population-based analysis of meningococcal disease mortality in the United States: 1990-2002.

Pediatr Infect Dis J. 2006 Mar;25(3):191-4. doi: 10.1097/01.inf.0000202065.03366.0c.

Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States.

Pediatrics. 2005 May;115(5):1220-32. doi: 10.1542/peds.2004-2514.

Epidemiology of Meningococcal Disease Outbreaks in the United States, 2009-2013.

Clin Infect Dis. 2019 Feb 1;68(4):580-585. doi: 10.1093/cid/ciy548.

Use of MenACWY-CRM vaccine in children aged 2 through 23 months at increased risk for meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2013.

MMWR Morb Mortal Wkly Rep. 2014 Jun 20;63(24):527-30.

引用本文的文献

Preventing invasive meningococcal disease in early infancy.

Hum Vaccin Immunother. 2022 Nov 30;18(5):1979846. doi: 10.1080/21645515.2021.1979846. Epub 2022 Apr 28.

Rationale for the Development of a Pentavalent Meningococcal Vaccine: A US-Focused Review.

Infect Dis Ther. 2022 Jun;11(3):937-951. doi: 10.1007/s40121-022-00609-9. Epub 2022 Mar 31.

Epidemiology of invasive meningococcal disease in Cyprus 2004 to 2018.

Euro Surveill. 2020 Jul;25(30). doi: 10.2807/1560-7917.ES.2020.25.30.1900534.

[Health Technology Assessment of meningococcal B vaccine (Trumenba) in adolescent in Italy].

J Prev Med Hyg. 2019 Dec 19;60(3 Suppl 2):E1-E94. doi: 10.15167/2421-4248/jpmh2019.60.3s2. eCollection 2019 Dec.

Optimal use of meningococcal serogroup B vaccines: moving beyond outbreak control.

Ther Adv Vaccines Immunother. 2018 Jun 21;6(3):49-60. doi: 10.1177/2515135518781757. eCollection 2018 May.

Diagnosis and Treatment of Childhood Meningitis Caused by Streptococcus bovis Group.

Curr Infect Dis Rep. 2016 Mar;18(4):11. doi: 10.1007/s11908-016-0519-8.

本文引用的文献

Notice to readers: final 2012 reports of nationally notifiable infectious diseases.

MMWR Morb Mortal Wkly Rep. 2013 Aug 23;62(33):669-82.

Recommendation of the Advisory Committee on Immunization Practices (ACIP) for use of quadrivalent meningococcal conjugate vaccine (MenACWY-D) among children aged 9 through 23 months at increased risk for invasive meningococcal disease.

MMWR Morb Mortal Wkly Rep. 2011 Oct 14;60(40):1391-2.

Licensure of a meningococcal conjugate vaccine for children aged 2 through 10 years and updated booster dose guidance for adolescents and other persons at increased risk for meningococcal disease--Advisory Committee on Immunization Practices (ACIP), 2011.

MMWR Morb Mortal Wkly Rep. 2011 Aug 5;60(30):1018-9.

Early clinical experience with a candidate meningococcal B recombinant vaccine (rMenB) in healthy adults.

Hum Vaccin. 2011 Jul;7(7):781-91. doi: 10.4161/hv.7.7.15997. Epub 2011 Jul 1.

Molecular testing of respiratory swabs aids early recognition of meningococcal disease in children.

Diagn Microbiol Infect Dis. 2011 Aug;70(4):427-34. doi: 10.1016/j.diagmicrobio.2011.03.018. Epub 2011 Jun 11.

Immunogenicity and safety of H influenzae type b-N meningitidis C/Y conjugate vaccine in infants.

Pediatrics. 2011 Jun;127(6):e1375-85. doi: 10.1542/peds.2009-2992. Epub 2011 May 29.

Summary of notifiable diseases: United States, 2009.

MMWR Morb Mortal Wkly Rep. 2011 May 13;58(53):1-100.

The Global Meningococcal Initiative: recommendations for reducing the global burden of meningococcal disease.

Vaccine. 2011 Apr 18;29(18):3363-71. doi: 10.1016/j.vaccine.2011.02.058. Epub 2011 Mar 3.

Updated recommendations for use of meningococcal conjugate vaccines --- Advisory Committee on Immunization Practices (ACIP), 2010.

MMWR Morb Mortal Wkly Rep. 2011 Jan 28;60(3):72-6.

Invasive meningococcal disease and travel.

J Infect Public Health. 2010 Dec;3(4):143-51. doi: 10.1016/j.jiph.2010.09.008. Epub 2010 Nov 11.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

The Burden of Infant Meningococcal Disease in the United States.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献